Results Announcements News Details

Indrayani Biotech Ltd consolidated sales up 107.88% on year in Q1FY2026, net profit jumped 808.33%

(17-Aug-26   22:53)

Indrayani Biotech Ltd share price crashed 8.91% to Rs 7.16. The Company's net profit surged by 808.33% to Rs 1.09 crore, while revenue from operations gained significantly 107.88% to Rs 72.78 crore in Q1FY26 over Q4FY25. The market capitalization of Other Agricultural Products industry group stocks on BSE stood at Rs 57130.8 crore, rising 6.64%. It has improved by 0.77% over last one week and gained upto 1.52% in last one month while the market capitalization of Indrayani Biotech Ltd has nosedived by 16.56% and 33.03% in the same period respectively. Profit before tax (PBT) of Indrayani Biotech Ltd stood at Rs 0.97 crore in Q1 FY26, tanking 88.34% year-on-year, and nosediving by 792.86% quarter-on-quarter. EBITDA came in at Rs 3 crore, plunging by 138.62% YoY and rallying 67.86% sequentially. Total expenses soared by 110.35% to Rs 69.92 crore in Q1FY26 over Q1FY25. During the quarter, cost of materials consumed stood at Rs 51.38 crore, surging by 96.86% YoY, while employee benefits expense was at Rs 7.49 crore, jumping 134.06% YoY. For the TTM ended FY26, revenue from operations plunged by 21.66% to Rs 130.23 crore, while net profit witnessed a sharp fall of 158.64% to Rs 6.11 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 2080% to Rs 3.13 crore, and PBT tanked by 152.32% to Rs 5.74 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 6.74 crore in FY26, as against Rs 30.35 crore in FY25. Indrayani Biotech Ltd tumbled by 45.79% in last one year, underperforming the benchmark BSE Sensex which has slipped by 3.21% during the same period.